Detail akcie Simulatns Plus online

Business Summary: Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Financial Summary: BRIEF: For the three months ended 30 November 2024, Simulations Plus Inc revenues increased 31% to $18.9M. Net income decreased 89% to $206K. Revenues reflect Software segment increase of 41% to $10.7M, Services segment increase of 19% to $8.2M, Americas segment increase of 33% to $14.5M, Asia segment increase of 33% to $1.7M. Net income was offset by Interest income decrease of 88% to $159K (income).